Effect of teriflunomide on cognitive abilities of patients with multiple sclerosis

被引：0
|
作者：
Lizhdvoy, V.
Kotov, S.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO2266
引用
收藏
页码：931 / 931
页数：1
相关论文
共 50 条
  • [31] Effect of teriflunomide on brain volume loss in patients with relapsing multiple sclerosis of differing ages in TEMSO
    Oh, Jiwon
    Wuerfel, Jens
    Khatri, Bhupendra
    Miller, Aaron E.
    Inshasi, Jihad Said
    Kim, Byoung Joon
    Saiz, Albert
    Lublin, Alex L.
    Poole, Elizabeth M.
    Sprenger, Till
    [J]. NEUROLOGY, 2020, 94 (15)
  • [32] Cognitive impairment in multiple sclerosis: the role of fine abilities assesment
    Passafiume, D.
    Caputi, N.
    Matrella, A.
    Di Giacomo, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 520 - 520
  • [33] Cognitive abilities as predictors of safety to drive in people with multiple sclerosis
    Lincoln, N. B.
    Radford, K. A.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 (01): : 123 - 128
  • [34] COGNITIVE-ABILITIES AND SPECT FINDINGS IN MULTIPLE-SCLEROSIS
    PASSAFIUME, D
    POZZILLI, C
    INCOCCIA, C
    BERNARDI, S
    PANTANO, P
    FIESCHI, C
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1990, 12 (01) : 74 - 74
  • [35] BUDGET IMPACT ANALYSIS OF TERIFLUNOMIDE USED FOR MULTIPLE SCLEROSIS PATIENTS IN RUSSIA
    Evdoshenko, E.
    Solodun, I
    Bashlakova, E.
    Holownia, M.
    Poliakova, K.
    Pokatilo, A.
    Khachanova, N.
    Davydovskaya, M.
    Skoromets, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A428 - A428
  • [36] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Amir Hadi Maghzi
    Maria K. Houtchens
    Paolo Preziosa
    Carolina Ionete
    Biljana D. Beretich
    James M. Stankiewicz
    Shahamat Tauhid
    Ann Cabot
    Idanis Berriosmorales
    Tamara H. W. Schwartz
    Jacob A. Sloane
    Mark S. Freedman
    Massimo Filippi
    Howard L. Weiner
    Rohit Bakshi
    [J]. Journal of Neurology, 2020, 267 : 2790 - 2796
  • [37] Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?
    Pourcher, Valerie
    Yeung, Jennifer
    Le Pimpec-Barthes, Francoise
    Maillart, Elisabeth
    Gibault, Laure
    Boussouar, Samia
    [J]. REVUE NEUROLOGIQUE, 2022, 178 (03) : 266 - 267
  • [38] Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
    Miller, Aaron E.
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (05) : 467 - 483
  • [39] Teriflunomide-exposed pregnancies in a French cohort of patients with multiple sclerosis
    Barataud-Reilhac, Astrid
    Kerbrat, Sandrine
    Roux, Jonathan
    Guilleux, Alice
    Polard, Elisabeth
    Leray, Emmanuelle
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (04) : 287 - 297
  • [40] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Maghzi, Amir Hadi
    Houtchens, Maria K.
    Preziosa, Paolo
    Ionete, Carolina
    Beretich, Biljana D.
    Stankiewicz, James M.
    Tauhid, Shahamat
    Cabot, Ann
    Berriosmorales, Idanis
    Schwartz, Tamara H. W.
    Sloane, Jacob A.
    Freedman, Mark S.
    Filippi, Massimo
    Weiner, Howard L.
    Bakshi, Rohit
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (10) : 2790 - 2796
12345